EUR RESPIR J
| 中国学者近期发表的论文 | |
|---|---|
| 1. | Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis. Author: Zhang Y, Li N, Zhang Y, Li H, Chen X, Wang S, Zhang X, Zhang R, Xu J, Shi J, Yung RC. Journal: Eur Respir J. 2012 Nov;40(5):1191-200. doi: 10.1183/09031936.00168011. Epub 2012 Mar 9. |
| 2. | Atorvastatin in pulmonary arterial hypertension (APATH) study. Author: Zeng WJ, Xiong CM, Zhao L, Shan GL, Liu ZH, Xue F, Gu Q, Ni XH, Zhao ZH, Cheng XS, Wilkins MR, He JG; Atorvastatin in Pulmonary Arterial Hypertension (APATH) Study Group. Collaborators (36)Wang GY, Cao H, Zhou DX, Zhang GC, Zhu XY, Zhang DZ, Shen JY, Chen C, Huang SA, Wang DJ, Wang LM, Wu GQ, Yang YH, Wang LH, Wu H, Cheng ZZ, Ji YQ, Tian HY, Guo YJ, Wu BX, Li MT, Xu YJ, Zeng HS, Hu SX, Wu GH, Zhang C, Zheng ZQ, Lv AK, Gu H, Jiang P, Sun TY, Yang ZW, Yang R, Yang TL, Yu ZX, Liu Q. Journal: Eur Respir J. 2012 Jul;40(1):67-74. doi: 10.1183/09031936.00149011. Epub 2012 Feb 23. |
| 3. | Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients. Author: Liu D, Liu QQ, Eyries M, Wu WH, Yuan P, Zhang R, Soubrier F, Jing ZC. Journal: Eur Respir J. 2012 Mar;39(3):597-603. doi: 10.1183/09031936.00072911. Epub 2011 Jul 7. |
| 4. | Silent aspiration in patients with exacerbation of COPD. Author: Zheng Z, Wu Z, Liu N, Chen P, Hou P, Wang X, Fu Y, Liang W, Chen R. Journal: Eur Respir J. 2016 Jun 23. pii: ERJ-00007-2016. doi: 10.1183/13993003.00007-2016. [Epub ahead of print] No abstract available. |
| 5. | Annual risk of tuberculosis infection in rural China: a population-based prospective study. Author: Gao L, Bai L, Liu J, Lu W, Wang X, Li X, Du J, Chen X, Zhang H, Xin H, Sui H, Li H, Su H, He J, Pan S, Peng H, Xu Z, Catanzaro A, Evans TG, Zhang Z, Ma Y, Li M, Feng B, Li Z, Guan L, Shen F, Wang Z, Zhu T, Yang S, Si H, Wang Y, Tan Y, Chen T, Chen C, Xia Y, Cheng S, Xu W, Jin Q; LATENTTB-NSTM study team. Journal: Eur Respir J. 2016 Jul;48(1):168-78. doi: 10.1183/13993003.00235-2016. Epub 2016 May 26. |
| 6. | Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. Author: Berry C, Yates TA, Seddon JA, Phillips PP, du Cros P; North London TB Journal Club. Journal: Eur Respir J. 2016 May;47(5):1591-2. doi: 10.1183/13993003.01646-2015. No abstract available. |
| 7. | Asthma and bronchiectasis exacerbation. Author: Mao B, Yang JW, Lu HW, Xu JF. Journal: Eur Respir J. 2016 Jun;47(6):1680-6. doi: 10.1183/13993003.01862-2015. Epub 2016 Apr 13. |
| 8. | An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey. Author: Pang Y, Du J, Qin ZZ, Greenwald Z, Liu Y, Mi F, Zhao Y, Li L. Journal: Eur Respir J. 2016 May;47(5):1584-7. doi: 10.1183/13993003.01854-2015. Epub 2016 Feb 25. No abstract available. |
| 9. | The bronchiectasis severity index and FACED score for bronchiectasis. Author: Guan WJ, Chen RC, Zhong NS. Journal: Eur Respir J. 2016 Feb;47(2):382-4. doi: 10.1183/13993003.01717-2015. No abstract available. |
| 10. | Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma. Author: Wang G, Baines KJ, Fu JJ, Wood LG, Simpson JL, McDonald VM, Cowan DC, Taylor DR, Cowan JO, Gibson PG. Journal: Eur Respir J. 2016 Apr;47(4):1123-33. doi: 10.1183/13993003.01098-2015. Epub 2015 Dec 23. |